Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

A. Casadevall; D. L. Goldman; M. Feldmesser

doi:10.1016/S0020-2452(97)83532-5

Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

A. Casadevall
, D. L. Goldman
, M. Feldmesser

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

Original language	English (US)
Pages (from-to)	247-257
Number of pages	11
Journal	Bulletin de l'Institut Pasteur
Volume	95
Issue number	4
DOIs	https://doi.org/10.1016/S0020-2452(97)83532-5
State	Published - 1997
Externally published	Yes

Keywords

Antibiotic resistance
HIV
Immunoglobulin
Opportunistic infection
RSV
Review
Septic shock
Therapeutics

ASJC Scopus subject areas

Applied Microbiology and Biotechnology

Access to Document

10.1016/S0020-2452(97)83532-5

Cite this

@article{54a265e000c44536a9dafa98d7971662,

title = "Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?",

abstract = "Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.",

keywords = "Antibiotic resistance, HIV, Immunoglobulin, Opportunistic infection, RSV, Review, Septic shock, Therapeutics",

author = "A. Casadevall and Goldman, \{D. L.\} and M. Feldmesser",

year = "1997",

doi = "10.1016/S0020-2452(97)83532-5",

language = "English (US)",

volume = "95",

pages = "247--257",

journal = "Bulletin de l'Institut Pasteur",

issn = "0020-2452",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Antibody-based therapies for infectious diseases

T2 - Renaissance for an abandoned arsenal?

AU - Casadevall, A.

AU - Goldman, D. L.

AU - Feldmesser, M.

PY - 1997

Y1 - 1997

N2 - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

AB - Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

KW - Antibiotic resistance

KW - HIV

KW - Immunoglobulin

KW - Opportunistic infection

KW - RSV

KW - Review

KW - Septic shock

KW - Therapeutics

UR - https://www.scopus.com/pages/publications/0031438485

UR - https://www.scopus.com/pages/publications/0031438485#tab=citedBy

U2 - 10.1016/S0020-2452(97)83532-5

DO - 10.1016/S0020-2452(97)83532-5

M3 - Review article

AN - SCOPUS:0031438485

SN - 0020-2452

VL - 95

SP - 247

EP - 257

JO - Bulletin de l'Institut Pasteur

JF - Bulletin de l'Institut Pasteur

IS - 4

ER -

Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this